巨大卵巢肿瘤的临床病理分析

IF 1.5 Q3 OBSTETRICS & GYNECOLOGY
Brahmana Askandar Tjokroprawiro, Khoirunnisa Novitasari, Renata Alya Ulhaq, Hanif Ardiansyah Sulistya
{"title":"巨大卵巢肿瘤的临床病理分析","authors":"Brahmana Askandar Tjokroprawiro,&nbsp;Khoirunnisa Novitasari,&nbsp;Renata Alya Ulhaq,&nbsp;Hanif Ardiansyah Sulistya","doi":"10.1016/j.eurox.2024.100318","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>This study aims to analyze giant ovarian tumors' clinical and pathological characteristics.</p></div><div><h3>Material and Methods</h3><p>This was an analytical observational study. Medical records of all patients with giant ovarian tumors who underwent surgery between January 2020 and June 2022 at Dr. Soetomo Academic Hospital, Surabaya, Indonesia, were analyzed.</p></div><div><h3>Results</h3><p>We analyzed 63 patients with ovarian tumors measuring &gt; 20 cm who underwent surgery at Dr. Soetomo Academic Hospital, Surabaya, Indonesia. The mean tumor size was 25.9 cm (largest size was 41 cm). There was no significant difference in tumor size between benign and malignant giant ovarian tumors (p = 0.261). Based on histopathological results, 66.67 % of giant ovarian tumors were malignant, 26.98 % were benign, and 6.35 % were borderline. Among the malignant tumors, the epithelial type accounted for 69 % of cases. Most giant ovarian tumors originated in the left adnexa (68.25 %). There was no significant difference in patient age (p = 0.511), tumor size (p = 0.168), malignancy (p = 0.303), and histopathological type (p = 0.232) regardless of adnexal side. CA125 levels did not differ significantly between malignant and benign giant ovarian tumors (p = 0.604). There was no correlation between malignant ovarian tumor size and CA125 levels, while there was a significant difference between CA125 levels and the adnexal side (p = 0.010).</p></div><div><h3>Conclusions</h3><p>Most giant ovarian tumors were malignant, diagnosed at an early stage, and predominantly epithelial type. CA125 levels did not correlate with the size of malignant ovarian tumors. Most giant ovarian tumors originate in the left adnexa.</p></div>","PeriodicalId":37085,"journal":{"name":"European Journal of Obstetrics and Gynecology and Reproductive Biology: X","volume":null,"pages":null},"PeriodicalIF":1.5000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590161324000383/pdfft?md5=783fc7a3a302fa5dabcbe2bbeb456931&pid=1-s2.0-S2590161324000383-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Clinicopathological analysis of giant ovarian tumors\",\"authors\":\"Brahmana Askandar Tjokroprawiro,&nbsp;Khoirunnisa Novitasari,&nbsp;Renata Alya Ulhaq,&nbsp;Hanif Ardiansyah Sulistya\",\"doi\":\"10.1016/j.eurox.2024.100318\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>This study aims to analyze giant ovarian tumors' clinical and pathological characteristics.</p></div><div><h3>Material and Methods</h3><p>This was an analytical observational study. Medical records of all patients with giant ovarian tumors who underwent surgery between January 2020 and June 2022 at Dr. Soetomo Academic Hospital, Surabaya, Indonesia, were analyzed.</p></div><div><h3>Results</h3><p>We analyzed 63 patients with ovarian tumors measuring &gt; 20 cm who underwent surgery at Dr. Soetomo Academic Hospital, Surabaya, Indonesia. The mean tumor size was 25.9 cm (largest size was 41 cm). There was no significant difference in tumor size between benign and malignant giant ovarian tumors (p = 0.261). Based on histopathological results, 66.67 % of giant ovarian tumors were malignant, 26.98 % were benign, and 6.35 % were borderline. Among the malignant tumors, the epithelial type accounted for 69 % of cases. Most giant ovarian tumors originated in the left adnexa (68.25 %). There was no significant difference in patient age (p = 0.511), tumor size (p = 0.168), malignancy (p = 0.303), and histopathological type (p = 0.232) regardless of adnexal side. CA125 levels did not differ significantly between malignant and benign giant ovarian tumors (p = 0.604). There was no correlation between malignant ovarian tumor size and CA125 levels, while there was a significant difference between CA125 levels and the adnexal side (p = 0.010).</p></div><div><h3>Conclusions</h3><p>Most giant ovarian tumors were malignant, diagnosed at an early stage, and predominantly epithelial type. CA125 levels did not correlate with the size of malignant ovarian tumors. Most giant ovarian tumors originate in the left adnexa.</p></div>\",\"PeriodicalId\":37085,\"journal\":{\"name\":\"European Journal of Obstetrics and Gynecology and Reproductive Biology: X\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2590161324000383/pdfft?md5=783fc7a3a302fa5dabcbe2bbeb456931&pid=1-s2.0-S2590161324000383-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Obstetrics and Gynecology and Reproductive Biology: X\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2590161324000383\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Obstetrics and Gynecology and Reproductive Biology: X","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590161324000383","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

本研究旨在分析巨大卵巢肿瘤的临床和病理特征。结果我们分析了在印度尼西亚泗水Dr. Soetomo学术医院接受手术治疗的63名卵巢肿瘤患者,这些患者的卵巢肿瘤大小为20厘米。肿瘤平均大小为 25.9 厘米(最大为 41 厘米)。良性和恶性巨大卵巢肿瘤的大小没有明显差异(P = 0.261)。根据组织病理学结果,66.67%的巨型卵巢肿瘤为恶性,26.98%为良性,6.35%为边缘性。在恶性肿瘤中,上皮型占 69%。大多数巨型卵巢肿瘤起源于左侧附件(68.25%)。患者年龄(p = 0.511)、肿瘤大小(p = 0.168)、恶性程度(p = 0.303)和组织病理学类型(p = 0.232)与附件侧无明显差异。恶性和良性巨大卵巢肿瘤的 CA125 水平无明显差异(p = 0.604)。恶性卵巢肿瘤的大小与 CA125 水平无相关性,而 CA125 水平与附件侧有显著差异(p = 0.010)。CA125水平与恶性卵巢肿瘤的大小无关。大多数巨型卵巢肿瘤起源于左侧附件。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Clinicopathological analysis of giant ovarian tumors

Objective

This study aims to analyze giant ovarian tumors' clinical and pathological characteristics.

Material and Methods

This was an analytical observational study. Medical records of all patients with giant ovarian tumors who underwent surgery between January 2020 and June 2022 at Dr. Soetomo Academic Hospital, Surabaya, Indonesia, were analyzed.

Results

We analyzed 63 patients with ovarian tumors measuring > 20 cm who underwent surgery at Dr. Soetomo Academic Hospital, Surabaya, Indonesia. The mean tumor size was 25.9 cm (largest size was 41 cm). There was no significant difference in tumor size between benign and malignant giant ovarian tumors (p = 0.261). Based on histopathological results, 66.67 % of giant ovarian tumors were malignant, 26.98 % were benign, and 6.35 % were borderline. Among the malignant tumors, the epithelial type accounted for 69 % of cases. Most giant ovarian tumors originated in the left adnexa (68.25 %). There was no significant difference in patient age (p = 0.511), tumor size (p = 0.168), malignancy (p = 0.303), and histopathological type (p = 0.232) regardless of adnexal side. CA125 levels did not differ significantly between malignant and benign giant ovarian tumors (p = 0.604). There was no correlation between malignant ovarian tumor size and CA125 levels, while there was a significant difference between CA125 levels and the adnexal side (p = 0.010).

Conclusions

Most giant ovarian tumors were malignant, diagnosed at an early stage, and predominantly epithelial type. CA125 levels did not correlate with the size of malignant ovarian tumors. Most giant ovarian tumors originate in the left adnexa.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
2.20
自引率
0.00%
发文量
31
审稿时长
58 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信